Busulfan-Induced Infertility May Deter Some Pediatric Patients From Bluebird, Other Gene Therapies

Partial Hold On Firm's Sickle Cell Therapy Lifted

Bluebird said 19 December the FDA had lifted a partial hold on its lovo-cel trial • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies